Potential in a single cancer cell to produce heterogeneous morphology, radiosensitivity and gene expression

Journal of Radiation Research

Volumn 46, Issue 1, 2005, Pages 43-50

  Ban, Sadayuki ^a   Ishikawa, Ken Ichi ^a   Kawai, Seiko ^a   Koyama Saegusa, Kumiko ^a   Ishikawa, Atsuko ^a   Shimada, Yutaka ^b   Inazawa, Johji ^c   Imai, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Dedifferentiation; Gene expression; Microarray; Morphology; Radiosensitivity

Indexed keywords

CELL ADHESION; CELL CULTURE; CLONING; DISEASES; IRRADIATION; MORPHOLOGY; OLIGONUCLEOTIDES;

CANCER CELLS; CARCINOMA TISSUES; CELL LINES; CULTURED CELL; DEDIFFERENTIATION; ESOPHAGEAL CARCINOMA; GENES EXPRESSION; RADIOSENSITIVITY; SINGLE CLONE; SUBCLONES;

GENE EXPRESSION;

ARTICLE; CANCER; CANCER CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL STRUCTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; MOLECULAR CLONING; RADIOSENSITIVITY; UPREGULATION; X IRRADIATION; CELL SIZE; CELL SURVIVAL; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; TUMOR CELL LINE; X RAY;

TUMOR PROTEIN;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SIZE; CELL SURVIVAL; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; RADIATION DOSAGE; RADIATION TOLERANCE; X-RAYS;

EID: 18044393821     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.46.43     Document Type: Article

References (26)

1. Nowell, P. C. (1976) The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194: 23-28.
2. Crook, J. M., Bahadur, Y. A., Robertson, S. J., Perry, G. A. and Esche, B.A. (1977) Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 79: 81-89.
3. Szeifert, G. T., Massager, N., Brotchi, J. and Levivier, M. (2002) Morphological redifferentiation in a malignant astrocytic tumor after gamma knife radiosurgery. J Neurosurg. 97: 627-630.
4. Canfield, S. E., Gans, T. H., Unger, P. and Hall, S. J. (2001) Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma? Tech. Urol. 7: 294-295.
5. Wheeler, J. A., Zagars, G. K., and Ayala, A. G. (1993) Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression, Cancer 71: 3783-3787.
6. Forus, A., Larramendy, M. L., Meza-Zepeda, L. A., Bjerkehagen, B., Godager, L. H., Dahlberg, A. B., Saeter, G., Knuutila, S. and Myklebost, O. (2001) Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genet. Cytogenet. 125: 100-111.
7. Grünwald, F., Menzel, C., Bender, H., Palmedo, H., Fimmers, R., Risse, J. and Biersack, H.J. (1998) Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J. Nuclear Med. 39: 1903-1906.
8. Ylagan, L. R. and Bhalla, S. (2001) Fine needle aspilation cytology of a dedifferentiatiated liposarcoma: report of a case with histologic and immunohistochemical follow-up. Acta Cytol. 45: 641-644.
9. Orosz, Z., Rohonyi, B., Luksander, A.and Szanto, J. (2000) Pleomorphic liposarcoma of a young woman following radiotherapy for epithelioid sarcoma. Pathol. Oncol. Res. 6: 287-291.
10. Gimm, O. (2001) Thyroid cancer, Cancer Lett. 163: 143-156.
11. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. and Tobe, T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284.
12. Shimada, Y., Maeda, M., Watanabe, G., Yamasaki, S., Komoto, I., Kaganoi, J., Kan, T., Hashimoto, Y., Imoto, I., Inazawa, J. and Imamura, M. (2003) Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. Clin. Cancer Res. 9: 243-249.
13. Ban, S., Setlow, R. B., Bender, M. A., Ezaki, H., Hiraoka, T., Yamane, M., Nishiki, M., Dohi, K., Awa, A. A., Miller, R. C., Parry, D. M., Mulvihill, J. J. and Beebe, G. W. (1990) Radiosensitivity of skin fibroblasts from atomic bomb survivors with and without breast cancer. Cancer Res. 50: 4050-4055.
14. Rozen, S. and Skaletsky, H. J. Code available at http://wwwgenome.wi.mit. edu/genome_software/other/primer3.html. Primer3, 1998.
15. http://fatigo.bioinfo.cnio.es/
16. Bai, J., Nakamura, H., Ueda, S., Kwon, Y.-W., Tanaka, T., Ban, S. and Yodoi, J. (1994) Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+) -induced cell cycle arrest. J. Biol. Chem. 279: 38710-38714.
17. Kirschmann, D. A., Seftor, E. A., Nieva, D. R. C., Mariano, E. A. and Hendrix, M. J. C. (1999) Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast. Cancer Res. Treat. 55: 127-136.
18. Kirschmann, D. A., Seftor, E. A., Fong, S. F. T., Nieva, D. R. C., Sullivan, C. M., Edwards, E. M., Sommer, P., Csiszar, K. and Hendrix, M. J. C. (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62: 4478-4483.
19. Akiri, G., Sabo, E., Dafni, H., Vadasz, Z., Kartvelishvily, Y., Gan, N., Kessler, O., Cohen, T., Resnick, M., Neeman, M. and Neufeld, G.. (2003) Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res. 63: 1657-1666.
20. Joberty, G., Perlungher, R. R. and Magara, I. G.. (1999) The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins. Mol. Cell. Biol. 19: 6585-6597.
21. Hirsch, D. S., Pirone, D. M. and Burbelo, P. D. (2001) A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes. J. Biol. Chem. 276: 875-883.
22. Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T. and Ackerman, S. L. (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419: 367-374.
23. Pati, D., Keller, C., Groudine, M. and Plon, S. E. (1997) Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. Mol. Cell Biol. 17: 3037-3046.
24. Fidler, I. J. and Hart, I. R. (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217: 998-1003.
25. Beyer, D. C. (2003) Brachytherapy for recurrent prostate cancer after radiation therapy. Seminar Radiat. Oncol. 13: 158-165.
26. Eastham, J. A., DiBlasio, C. J. and Scardino, P. T. (2003) Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy. Curr. Urol. Rep. 4: 211-215.